CoChat

Prevalence of advanced HIV disease in sub-Saharan Africa: a multi-country analysis of nationally representative household surveys

Open access
Stelzle, Dominik, Rangaraj, Ajay, Jarvis, Joseph N, Razakasoa, Nirina H, Perrin, George, Low-Beer, Daniel, Doherty, Meg, Ford, Nathan, Dalal, Shona · 2025 · The Lancet Global Health

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Advanced HIV disease (AHD) is a critical stage in the progression of HIV infection and is associated with heightened susceptibility to opportunistic infections, malignancies, and other life-threatening complications. Estimates of the burden of AHD in sub-Saharan Africa are scarce but are needed for programme planning which includes the allocation of resources and the monitoring of outcomes. The aim of the study was to assess the prevalence of and the number of people living with HIV with AHD. METHODS: ). We analysed the prevalence of AHD by various demographic and socioeconomic factors; we then estimated the number of individuals with AHD in sub-Saharan Africa by combining these proportions with the latest UNAIDS HIV estimates for the region by the treatment and care cascade. We also assessed policies related to the provision of the recommended package of care for the diagnosis and management of AHD. FINDINGS: . AHD was more common among males than females (13·2% vs 8·0%) and differed across the treatment cascade: 15·4% among people living with HIV who did not know their HIV status, 20·9% among people who knew their status but were not on antiretroviral treatment (ART), 29·5% among people who were on ART but not virally suppressed, and 4·3% among people who were virally suppressed. Extrapolating these results to sub-Saharan Africa yielded an estimated 1·88 million people living with AHD (uncertainty interval [UI] 1·58-2·20); 920 000 (UI 770 000-1·07 million) females and 970 000 (UI 810 000-1·13 million) males. INTERPRETATION: Despite advances in ART that have transformed HIV into a manageable chronic condition, a substantial number of people continue to develop AHD. These figures highlight the need for urgent and innovative programmatic improvements in monitoring, prevention, testing, and diagnosis of AHD in the context of well-established and maturing ART programmes. FUNDING: None.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2214-109x(24)00538-2

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Proportion of people living with HIV with CD4 count below 200 cells per mm3 by country (A), the treatment cascade and sex (B), and various demographic and socioeconomic factors (C) ART=antiretroviral treatment.
Figure 1 Proportion of people living with HIV with CD4 count below 200 cells per mm3 by country (A), the treatment cascade and sex (B), and various demographic and socioeconomic factors (C) ART=antiretroviral treatment.CC BY · PubMed Central
Figure 2 Stacked bar charts of the distribution of people living with HIV with CD4 count above and below 200 cells per mm3 by treatment cascade and country (A) Proportion of people with CD4 count ≥200 cells per mm3 and <200 cells per mm3 disaggregated by the treatment cascade. (B) Distribution of people on each step of the treatment cascade among all people with CD4 count <200 cells per mm3. ART=antiretroviral treatment.
Figure 2 Stacked bar charts of the distribution of people living with HIV with CD4 count above and below 200 cells per mm3 by treatment cascade and country (A) Proportion of people with CD4 count ≥200 cells per mm3 and <200 cells per mm3 disaggregated by the treatment cascade. (B) Distribution of people on each step of the treatment cascade among all people with CD4 count <200 cells per mm3. ART=antiretroviral treatment.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 2

  1. WHO Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy 2017 World Health Organization 29341560
  2. WHO Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach 2021 World Health Organization 34370423

Cited by

See all 35

Metadata

Authors
Stelzle, D., Rangaraj, A., Jarvis, J. N., Razakasoa, N. H., Perrin, G., Low-Beer, D., Doherty, M., Ford, N., & Dalal, S.
Affiliations
  • World Health Organization (CH)
  • London School of Hygiene & Tropical Medicine (GB)
  • University of Cape Town (ZA)
Corresponding author
Dalal, Shona
Venue
The Lancet Global Health
Publisher
Elsevier BV
Published
2025-03
Volume
13
Issue
3
Pages
e437-e446
ISSN
2214-109X (ISSN-L)
OpenAlex
W4407946916
Cited by
35
References
23
Citations by year
2026: 22 · 2025: 13
FWCI
26.70
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet Global Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
Funders
World Health Organization
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › HIV/AIDS Impact and Responses
  • Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Keywords
advanced HIV disease, HIV prevalence, sub-Saharan Africa, antiretroviral therapy, viral suppression, treatment cascade, people living with HIV, sex differences, opportunistic infections
MeSH terms
Adolescent, Adult, Female, Humans, Male, Middle Aged, Surveys and Questionnaires, HIV Infections, Prevalence, Africa South of the Sahara, CD4 Lymphocyte Count, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of advanced HIV disease in sub-Saharan Africa: a multi-country analysis of nationally representative household surveys. https://app.cochat.ai/papers/10.1016/s2214-109x(24)00538-2
The paper
Stelzle, D., Rangaraj, A., Jarvis, J. N., Razakasoa, N. H., Perrin, G., Low-Beer, D., Doherty, M., Ford, N., & Dalal, S. (2025). Prevalence of advanced HIV disease in sub-Saharan Africa: a multi-country analysis of nationally representative household surveys. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(24)00538-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.